Levolta Pharmaceuticals Receives U.S. Patent for Novel Investigational Therapy for Controlling Osteoarthritis
30 oct. 2014 10h54 HE
|
Levolta Pharmaceuticals, Inc.
BETHLEHEM, Pa., Oct. 30, 2014 (GLOBE NEWSWIRE) -- Levolta Pharmaceuticals, Inc., an emerging leader in developmental osteoarthritis (OA) therapy, announced today that the U.S. Patent and Trademark...
Elsevier Publishes New Books on Bone and Endocrine Disease
11 sept. 2014 04h00 HE
|
Elsevier, Inc.
WALTHAM, MA--(Marketwired - September 11, 2014) - Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced the publication of four new...